The effectiveness of gentamicin administered by the intranasal route in healthy human volunteers was studied. Thirty minutes after gentamicin in a solution of 1% sodium glycocholate was administered at 2 mg/kg of body weight, gentamicin concentrations of 2.48 ± 0.42 mg/ml were present in the sera. Serum concentrations decreased to 0.94 ± 0.13 mg/ml at 180 min. No serious side effects were observed. There was slight local irritation after a single dose. When administered intranasally without glycocholate, gentamicin was not present in the sera in detectable amounts.
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In previous studies with laboratory animals (4), it was shown that absorption of aminoglycosides from the gastrointestinal tract can be enhanced by coadministration with nonionic surfactants. Similar techniques have been used to increase the absorption of insulin and heparin from a number of mucosal surfaces (6) (7) (8) . Others have described enhanced absorption of insulin coadministered with nonionic surfactants in dogs (2) and normal and diabetic humans (3). This communication reports increased absorption of gentamicin from the nasal passages of healthy human subjects when the antibiotic was given in a solution with sodium glycocholate.
Seven individuals (five men and two women of the laboratory personnel) volunteered to participate in the study after its purpose and possible hazards were explained to them. All were in good health, none were taking any medication, and all had hematograms, serum electrolyte levels, and liver and renal function tests that were within normal limits.
Gentamicin sulfate and sodium glycocholate were obtained from Sigma Chemical Co., St. Louis, Mo.
Gentamicin was administered as a solution of micin intramuscularly (see below).
Blood samples were drawn from peripheral veins 0, 30, 60, 90, 120, 150, and 180 min after administration. Sera from these samples were assayed for gentamicin content by a disk agar plate diffusion method (5), with Staphylococcus epidermidis as the test organism. Samples in triplicate were adsorbed on paper disks on a Mueller-Hinton agar plate and incubated overnight at 37°C, along with standards prepared by dissolving a known amount of gentamicin in human serum. The actual concentrations in the test samples were determined from the corresponding inhibition zones plotted on a semilogarithmic graph. The Student t test was used for statistical analysis.
The activity of gentamicin was unchanged when mixtures of gentamicin and sodium glycocholate at different serum concentrations were assayed in vitro. Table 1 shows gentamicin concentrations attained in sera after administration of gentamicin (2 mg/kg) in a solution with 1% sodium glycocholate. Peak concentrations of 2.3 to 3.4 ,ug/ml were attained after 30 min in four subjects and after 60 min in the other three. Gentamicin concentrations decreased gradually over 180 min. Some recipients of this combination complained of mild nasal irritation, but the discomfort was not severe enough to warrant stopping the experiments. No other side effects were observed. Amounts of gentamicin in sera were below detectable levels when 2 mg of gentamicin per kg was given intranasally in a saline solution without glycocholate.
To evaluate the effectiveness of the route of administration, concentrations of gentamicin in sera were attained with intramuscular doses of 0.3 to 1.0 mg/kg (Table 2) . After a 0.3-mg dose, gentamicin serum levels were similar to those attained after an intranasal 2-mg/kg dose; substantially higher levels were attained after a 1.0-mg/kg dose. This study shows that significant concentrations of gentamicin were obtained in the sera of human subjects after intranasal administration of the antibiotic in a solution with sodium glycocholate. Intranasal administration can be tolerated better than injection by many patients, and the mild irritation of the nasal mucosa after a single dose did not appear to be serious. The presence of the surfactant glycocholate was required to obtain a significant concentration of the antibiotic in the circulation. The mode of action of the surfactant is as yet unclear. It has been suggested that the surfactant can lead to alteration in cell membrane permeability patterns (1).
Administration of gentamicin via the intranasal route could overcome the limited therapeutic application of these agents. Further studies should be pursued to evaluate the tolerability and benefit of administering the above combination via the intranasal route. 
